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Summary
 
The commitment, differentiation, and expansion of mainstream 
 
a
 
/
 
b
 
 T cells during ontogeny
depend on the highly controlled interplay of signals relayed by cytokines through their recep-
tors on progenitor cells. The role of cytokines in the development of natural killer (NK)1
 
1
 
 nat-
ural T cells is less clearly understood. In an approach to define the role of cytokines in the com-
mitment, differentiation, and expansion of NK1
 
1
 
 T cells, their development was studied in
common cytokine receptor 
 
g
 
 chain (
 
g
 
c) and interleukin (IL)-7 receptor 
 
a
 
 (IL-7R
 
a
 
)–deficient
mice. These mutations block mainstream 
 
a
 
/
 
b
 
 T cell ontogeny at an early prethymocyte stage.
Natural T cells do not develop in 
 
g
 
c-deficient mice; they are absent in the thymus and periph-
eral lymphoid organs such as the liver and the spleen. In contrast, NK1
 
1
 
 T cells develop in
IL-7R
 
a
 
–deficient mice in the thymus, and they are present in the liver and in the spleen.
However, the absolute number of NK1
 
1
 
 T cells in the thymus of IL-7R
 
a
 
–deficient mice is re-
duced to 
 
z
 
10%, compared to natural T cell number in the wild-type thymus. Additional data
revealed that NK1
 
1
 
 T cell ontogeny is not impaired in IL-2– or IL-4–deficient mice, suggest-
ing that neither IL-2, IL-4, nor IL-7 are required for their development. From these data, we
conclude that commitment and/or differentiation to the NK1
 
1
 
 natural T cell lineage requires
signal transduction through the 
 
g
 
c, and once committed, their expansion requires signals re-
layed through the IL-7R
 
a
 
.
 
N
 
atural T (NT) cells are a distinct lineage of lympho-
cytes whose function is thought to be immunoregu-
latory in nature because they secrete a wide variety of cy-
tokines, most notably IL-4, upon activation. They express
both natural killer (NKR-P1) and T (
 
a
 
/
 
b
 
 and 
 
g
 
/
 
d
 
 TCR)
cell markers. In mice, they are present in the liver, bone
marrow, spleen, lymph node, and postnatal thymus (for re-
view see reference 1). The development of CD4
 
1
 
8
 
2
 
 or
CD4
 
2
 
8
 
2
 
 NT cells depends on the expression of nonclassi-
cal antigen presenting molecules such as CD1d1 (2–4) and
possibly H-2TL (5). They express highly conserved 
 
a
 
/
 
b
 
TCR; a large majority of them express V
 
a
 
14J
 
a
 
281 (85%)
paired with V
 
b
 
8.2 (up to 70%) (6, 7). A similar subset of T
cells also exists among the human peripheral blood
CD4
 
2
 
8
 
2
 
 lymphocytes (8, 9). Hence, NT cells are predicted
to serve an evolutionarily conserved function. Although
this function of NT cells remains elusive, their selective ab-
sence in autoimmune prone mice, such as MRL-
 
lpr
 
/
 
lpr
 
,
B6-
 
lpr
 
/
 
lpr
 
, C3H-
 
gld
 
/
 
gld
 
, and BWF
 
1
 
 (10, 11) as well as non-
obese diabetic (NOD; 12), suggests a role in the control of
the disease. Moreover, the ability to delay or prevent the
onset of disease either by the adoptive transfer of NKR-
P1
 
1
 
 splenocytes (10) that includes both natural killer and
NT cells, or by the administration of recombinant IL-4
(13), underscore the importance of NT cells in the physiol-
ogy of normal immune responses.
Here we report that: (
 
a
 
) commitment and/or differentia-
tion to NT cell lineage requires signaling through the com-
mon cytokine receptor 
 
g
 
 chain (
 
g
 
c) because 
 
g
 
c
 
0/0
 
 mice do
not develop NKR-P1
 
1
 
 T cells in the thymus or in the pe-
ripheral lymphoid organs, (
 
b
 
) the expansion of the commit-
ted NT cells requires signals relayed through the IL-7R
 
a
 
chain because although IL-7R
 
a
 
0/0
 
 mice develop NKR-P1
 
1
 
cells, they are dramatically reduced in numbers compared to
  
332
 
Distinct Roles for 
 
g
 
c and IL-7R
 
a
 
 in Natural T Cell Development
 
the wild type, and (
 
c
 
), signal(s) transduced through 
 
g
 
c is not
mediated by IL-2, IL-4, or IL-7 because neither IL-2
 
0/0
 
,
IL-4
 
0/0
 
, nor IL-7R
 
a
 
0/0
 
 mutations affect NT cell develop-
ment.
 
Materials and Methods
 
Mice.
 
B6.IL-2
 
0/0
 
 and IL-7R
 
a
 
0/0
 
 mice were purchased from
the Jackson Laboratory (Bar Harbor, ME); B6.IL-2
 
0/0
 
 were pro-
vided by D. Serreze (The Jackson Laboratory). R. Morawetz
(National Institute of Allergy and Infectious Diseases, Bethesda,
MD) provided B6.IL4
 
0/0
 
 (14) and D. Roopenian (The Jackson
Laboratory) provided B6.
 
b
 
2m
 
0/0
 
 and B6.IL-4
 
0/0
 
 mice. B6.
 
g
 
c
 
0/Y
 
and B6.IL-7R
 
a
 
0/0
 
 mice were bred and genotyped at the National
Heart, Lung and Blood Institute (Bethesda, MD; 15) and Immu-
nex (Seattle, WA; 16), respectively.
 
Mononuclear Cell Preparation.
 
Mononuclear cells (MNC) from
thymus and spleen were prepared by standard techniques. Intra-
hepatic MNC were prepared from minced liver lobes pressed
through a wire mesh. The cells were suspended in 50 ml of
RPMI-1640 (GIBCO BRL, Gaithersburg, MD) supplemented
with 5% FCS (Hyclone Labs., Logan, UT) and allowed to settle
for 
 
z
 
10 min on ice. Liver MNC were separated from the hepa-
tocytes by density centifugation over lympholyte M (Cederlane
Labs. Ltd., Hornby, Canada). Cells at the interface were collected
and washed with RPMI supplemented with 5% FCS.
 
Flow Cytometry.
 
Thymocytes (1–2 
 
3
 
 10
 
7
 
) of individual ani-
mals 6 wk or older were stained for three-color flow cytometric
analyses, as described previously (5), with anti–heat stable antigen
(HSA)-PE (M1/69), anti–CD8
 
a
 
-PE (53-6.7), anti–CD44-FITC
(IM7), and anti–NKR-P1 (NK1.1)-biotin (PK136), anti–TCR-
 
b
 
-biotin (H57-597), or anti–V
 
b
 
8.1,8.2-biotin (MR5-2). Thy-
mocytes were also stained with anti–Ly6C-FITC (AL-21). When
staining with anti–IL-2R
 
b
 
-PE (TM-
 
b
 
1), anti–HSA-FITC, and
anti–CD8
 
a
 
-FITC were used to electronically gate in the HSA
 
low
 
CD8
 
low
 
 population. The biotinylated antibody was stained with
streptavidin-RED670 (GIBCO BRL). HSA
 
low
 
CD8
 
low
 
 thymocytes
were electronically gated and either CD44
 
1
 
NKR-P1
 
1
 
, CD44
 
1
 
TCR-
 
a
 
/
 
b
 
1
 
, and CD44
 
1
 
V
 
b
 
8.1,8.2
 
1
 
, Ly6C
 
high
 
NKR-P1
 
1
 
, IL-2Rb1
NKR-P11, or IL-2Rb1TCR-a/b1 NT cells were analyzed by
flow cytometry using a FACScanÒ (Becton Dickinson, Moun-
tain View, CA). Intrahepatic NT cells were stained with anti–
NKR-P1-PE and anti–TCR-b-biotin or with anti–TCR-a/b-
PE and anti–NKR-P1-biotin. Splenocytes were stained with
anti–B220-FITC (RA3-6B2), anti–TCR-a/b-PE and anti–NKR-
P1-biotin after blocking with anti-Fcg III/II receptor antibody
(2.4G2) for at least 15 min. NKR-P11TCR-a/b1 cells were an-
alyzed directly (liver) or after electronic gating within B220null
MNC (spleen). All antibodies used in these experiments were
purchased from PharMingen (San Diego, CA). Thymic NT cell
number was calculated from the percentages of the double-
positive CD441 and NKR-P11, TCR-a/b1 or Vb8.1,8.21
thymocytes within the HSAlowCD8low subset as described previ-
ously (5).
Results
NT Cell Ontogeny in the Thymus of gc, IL-7Ra–, IL-2–
and IL-4–deficient Mice. The loss of gc expression as found in
X-linked severe combined immunodeficiency patients or
in mice results in impaired development of mainstream a/b
T cells (15, 17). To determine whether gc deficiency af-
fects NT cell ontogeny, we examined their development in
the thymus of gc0/Y mice backcrossed to C57BL/6 for 4–8
generations.  gc0/Y mice, .6 wk old, do not develop
HSAlowCD8low CD44highNKR-P11 thymocytes, whereas
they are detected in the gc1/Y wild-type littermates (Fig.
1). Thus, akin to mainstream T cells, signaling through gc
is important for NT cell ontogeny.
gc serves as an essential component of the multimeric re-
ceptors for IL-2, IL-4, IL-7, IL-9, and IL-15 (18). To deter-
mine which of the cytokines that use gc receptor affect NT
cell development, the thymi of .6-wk-old B6.IL-20/0,
B6.IL-40/0 and B6.IL-7Ra0/0 mice were analyzed. Main-
stream T lymphocyte development is impaired in B6.IL-7
Ra0/0 mice, but proceeds normally in B6.IL-20/0 (19) and
B6.IL-40/0 (20) mice. All three mutant mice develop
CD44highNKR-P11 T cells (Fig. 2 A). The repertoire of
a/b-TCR is skewed towards Vb8.1,8.2 usage in .40%
(the percentage of TCR-a/b1 thymocytes that are Vb8.1,
8.21) of these NT cells (Fig. 2 A). Further data revealed
that the NT cells that develop in B6.IL-40/0 and B6.IL-7
Ra0/0 mice also express Ly6C (Fig. 2 B) and that all the
three mutant mice express IL-2Rb (Fig. 2 C) similar to the
NK11 T cells that develop in the wild-type C57BL/6
mice. These data suggest that neither IL-2, IL-4, IL-7, nor
thymic stromal-derived lymphopoietin (TSLP; IL-7Ra is a
receptor component of IL-7 and TSLP; 16) are required
for NT cell ontogeny.
To determine the absolute number of NT cells in the
wild-type and the various mutant mice, thymocytes from
them were electronically gated in the HSAlowCD8low popu-
lation. The actual number of HSAlowCD8low cells was cal-
culated from the observed percentages of this population,
and the initial yield of thymocytes harvested from individ-
ual animals. Corresponding to the small size of the thymus
(16), the number of HSAlowCD8low cells was dramatically
reduced to z5% of the wild type in IL-7Ra0/0 mice (Fig. 2
D). The absolute number of CD441NKR-P11 T cells
within the HSAlowCD8low population is reduced to z40%
of wild type in IL-7Ra0/0 mice (Fig. 2 E, top). However,
IL-7Ra0/0 thymus contains only up to 10% of NT cells
that express TCR-a/b and Vb8.1,8.2 compared to those
of the wild type (Fig. 2 E, middle and bottom). The remain-
ing CD441NKR-P11 thymocytes in the IL-7Ra0/0 mice
are probably natural killer cells that also express these mark-
Figure 1. Common cytokine
receptor gc-deficient mice do not
develop thymic NTa/b cells.
Dot plots displaying CD441
NKR-P11 and CD441TCR-
a/b1 T cells among HSAlow
CD8low thymocytes of B6.gc0/Y
(seventh generation backcross to
C57BL/6) and B6.IL-2Rgc1/Y
littermates. HSAlowCD8low thy-
mocyte population was electron-
ically gated and CD44highNKR-
P11 T cells were analyzed with a
FACScanÒ flow cytometer.333 Boesteanu et al. Brief Definitive Report
ers, but not the TCR-a/b (22). The reduced number of
NT cells in the IL-7R0/0 mice then corresponds to the
small size of its thymus (16). In contrast, the absolute num-
ber of NT cells in IL-20/0 mice is increased by 1.5–2-fold
compared to the number of NKR-P11 T cells in wild-type
animals (Fig. 2 E). These data suggest that signals delivered
through the IL-7Ra are not only important in maintaining
thymic cellularity, but are also essential for the expansion of
NT cells.
NT Cells in the Peripheral Lymphoid Organs of gc, IL-7Ra,
and IL-2–deficient Mice. NT cells are also present in pe-
ripheral lymphoid organs such as the liver, spleen, bone
marrow, and lymph nodes; they also form a subset of in-
traepithelial lymphocytes of the gut (23). It is at present not
clear whether NT cells develop in situ in these organs or
whether they home here after their genesis in the thymus
(22, 24, 25). To determine whether gc, IL-7Ra, and IL-2
deficiency affect NT cell development and/or homing to
the liver and spleen, the presence of NKR-P11TCR-a/b1
cells was analyzed in these mutant animals. We find that gc
null mice contain dramatically reduced levels of NT cells in
the liver and spleen (Fig. 3). IL-7Ra0/0 mice contained re-
duced numbers of NT cells in the liver (z60% of wild
type; Fig. 3 A) and in the spleen (z25% of wild type; Fig. 3
B). In contrast, IL-2 null mutations had increased levels of
NKR-P11 T cells in the liver, but remained about the
same in the spleen (Fig. 3). Thus, although gc is required
for the development and/or homing of this subset of T
Figure 2. IL-2–, IL-4–, and IL-7Ra–deficient mice develop thymic NTa/b T cells. (A) Dot plots
of CD44highNKR-P11, CD44highTCR-a/bmed, and CD44highTCR-b8.1,8.2med T cells among
HSAlowCD8low thymocytes of B6.IL-20/0 (n 5 5), B6.IL-40/0 (n 5 6) and B6.IL-7Ra0/0 mice (n 5
6). (B) Dot plots of Ly6ChighNKR-P11 T cells among HSAlowCD8low thymocytes. (C) Dot plots of
IL-2 Rb1NKR-P11 (B6.IL-40/0 and B6.IL-7Ra0/0) and of IL-2Rb1TCR-a/b1 (B6.IL-20/0 and
B6.IL-7Ra0/0) T cells among HSAlowCD8low thymocytes. In B and C, the percentage of NT cells was
almost equal in B6.IL-40/0, about half in B6.IL-7Ra0/0, or up to twofold greater in B6.IL-20/0 com-
pared with those in the wild type. (D) Absolute numbers of HSAlowCD8low thymocytes calculated as
the thymocyte number times the fraction of this subset. (E) Thymic NT cells in wild-type, IL-20/0,
IL-40/0 and IL-7Ra0/0 mice. NT cell number was calculated from the percentages of the double-posi-
tive CD441 and NKR-P11, TCR-a/b1 or Vb8.1,8.21 thymocytes within the electronically gated
HSAlowCD8low population in D as described previously (5).334 Distinct Roles for gc and IL-7Ra in Natural T Cell Development
cells to the liver and spleen, the signaling for this process
does not require IL-2. Additionally, it is unclear whether
IL-7Ra null mutation affects the development and/or
homing of NT cells to the periphery, or whether it affects
the expansion of this T cell subset in the liver and spleen as
it does in the thymus.
Discussion
The requirement for signal transduction through gc for
NT cell development that does not involve IL-2 and IL-4
as well as, by extension, IL-7 and TSLP (evidenced by their
development in IL-7Ra0/0 thymocytes) as the soluble me-
diator is noteworthy. Thus, the lack of NT cells in gc0/Y
mice might be a reflection on the requirement for IL-9, IL-15,
and/or an as yet unidentified cytokine as the signal trans-
ducer for their development. NKR-P11 cells do not de-
velop in mice with dysregulated expression of IL-2Rb (26)
or when the IL-2Rb function is blocked with specific anti-
body (27). Whereas IL-9 uses only gc as part of its receptor
complex (28, 29), IL-15 function depends on both the
IL-2Rb and gc (30). This suggests that IL-15 or a hitherto-
fore undefined cytokine that uses both IL-2Rb and gc
specifies the soluble mediator function for NT cell ontog-
eny. If indeed an IL-2Rb and gc-dependent cytokine(s)
serves this function, how it selectively turns on NT cell de-
velopment in fetal day 9 livers (25), and later in post-natal
thymus (7), remains to be determined.
Human and mouse NK cells are predicted to develop
from bipotential T/NK progenitor cells that commit to ei-
ther T or NK cell lineage depending on the microenviron-
ment of the developing precursor. Recent evidence sug-
gests that the commitment to the NK lineage is strongly
influenced by IL-15 (31–33). If NT and NK cells have a
common precursor, then our data are consistent with the
hypothesis that commitment to NKR-P11 T cell lineage
might be influenced by signals mediated by IL-15.
Two possible mechanisms can explain the lack of NT
cell development in gc0/Y mice. Signaling through the gc
may be critical for the commitment of the precursor cell to
the NT cell lineage. An alternative mechanism would be
that further differentiation of the already committed NT
cells cannot proceed in the absence of signals from the gc.
Current evidence supports the latter mechanism. It was re-
cently demonstrated that gc null mice develop Va14 and
Vb8 positive, the conserved TCR expressed by NT cells
(6, 7), thymocytes within their CD4282 subset (34). How-
ever, these thymocytes poorly respond to in vitro cross-
linking of their TCR by secreting IL-4 (34), a characteristic
of mature NT cells (35). This would suggest that commit-
ment to NT cells has occurred in the thymus of gc null
mice, but the committed precursor has not completely dif-
ferentiated into this lineage.
Although IL-7Ra0/0 mice develop NT cells, their abso-
lute numbers in the thymus are dramatically lower (z10%)
than those found in the wild-type mice. In vitro stimula-
tion of unfractionated thymocytes with IL-7 results in the
selective expansion of CD4182 and CD4282 thymocytes
that express the Vb8.2 TCR (36). In keeping with this and
consistent with our results is the finding that IL-7 cytokine-
deficient mice develop NT cells, but in reduced numbers
(37). In this respect, it is also noteworthy that type I diabe-
Figure 3. NTa/b cells do not develop in peripheral lymphoid organs of gc-deficient mice, but develop in IL-7Ra0/0 and IL-20/0 animals. Dot plots
displaying NKR-P11TCR-a/b1 cells among mononuclear cells isolated from the liver (A) and spleen (B) of wild-type and mutant mice. Liver NTa/b
cells were stained with anti–NKR-P1-PE and anti–TCR-b-biotin (B6.gc0/Y and B6.IL-7Ra0/0) or anti–TCR-b-PE and anti–NKR-P1-biotin (B6.IL-21/0
and B6.IL-20/0). Splenic NTa/b cells were stained with anti–B220-FITC, anti-TCR-b-PE and anti-NKR-P1-biotin, and identified among B220null
splenocytes. In all cases, the biotinylated antibodies were detected by staining with streptavidin-RED670. The staining pattern of intrahepatic NT cells
was observed in over 20 different preparations (see also reference 4).335 Boesteanu et al. Brief Definitive Report
tes-prone NOD mice do not secrete IL-4 in response to in
vivo cross-linking of TCR (12) suggesting that they do not
develop NT cells. Type I diabetes is a Th1 disease that can
be delayed or prevented by the administration of IL-4 to
prediabetic NOD mice (13). The lack of IL-4 response of
NOD mice to in vivo TCR cross-linking is reversible by
IL-7 stimulation in vitro (12). Thus, in conclusion, akin to
mainstream T cells, the commitment and/or differentiation
to the NT cell lineage depends on signal transduction
through the gc, and once committed, their expansion re-
quires signals relayed through the IL-7Ra.
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